More on BOLD
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.29 |
|
|||
| Open | $11.77 | ||||
| 52 Wk High | $20.74 | ||||
| 52 Wk Low | $13.06 | ||||
| Day High | $11.90 | ||||
| Day Low | $11.17 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 151,319 | ||||
- Form SC 13G Boundless Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
- Form SC 13G Boundless Bio, Inc. Filed by: Nextech VI GP S.A.R.L.
- Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
- Form SC 13G Boundless Bio, Inc. Filed by: FMR LLC
- Form SC 13G Boundless Bio, Inc. Filed by: BAYER HEALTHCARE LLC
- Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting
- Form 4 Boundless Bio, Inc. For: Apr 02 Filed by: Lim Jonathan E
- Form 4 Boundless Bio, Inc. For: Apr 02 Filed by: ARCH Venture Partners X Overage, L.P.
- Form 4 Boundless Bio, Inc. For: Apr 02 Filed by: Burow Kristina
- Form 4 Boundless Bio, Inc. For: Apr 02 Filed by: BYBEE CLINTON
Entities mentioned with BOLD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Cowen & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Piper Jaffray | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
